Annual Short Term Debt
$1.33 M
-$3.18 M-70.43%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual short term debt is $1.33 million, with the most recent change of -$3.18 million (-70.43%) on December 31, 2023.
- During the last 3 years, RGLS annual short term debt has fallen by -$3.32 million (-71.32%).
- RGLS annual short term debt is now -94.30% below its all-time high of $23.40 million, reached on December 31, 2014.
Performance
RGLS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
N/A
September 30, 2024
Summary
- RGLS quarterly short term debt is not available.
Performance
RGLS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
RGLS Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.4% | - |
| 3 y3 years | -71.3% | - |
| 5 y5 years | -92.0% | - |
RGLS Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.4% | at low | ||
| 5 y | 5-year | -90.9% | at low | ||
| alltime | all time | -94.3% | -100.0% |
Regulus Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $540.00 K(-59.5%) |
| Dec 2023 | $1.33 M(-70.4%) | $1.33 M(-37.3%) |
| Sep 2023 | - | $2.13 M(-27.2%) |
| Jun 2023 | - | $2.92 M(-21.4%) |
| Mar 2023 | - | $3.72 M(-17.6%) |
| Dec 2022 | $4.51 M(-3.0%) | $4.51 M(+0.7%) |
| Sep 2022 | - | $4.48 M(+171.1%) |
| Jun 2022 | - | $1.65 M(+100.0%) |
| Mar 2022 | - | $826.00 K(-82.3%) |
| Sep 2021 | - | $4.67 M(+0.1%) |
| Jun 2021 | - | $4.66 M(+0.1%) |
| Mar 2021 | - | $4.66 M(+0.1%) |
| Dec 2020 | $4.65 M(-68.2%) | $4.65 M(-65.9%) |
| Sep 2020 | - | $13.65 M(-6.8%) |
| Jun 2020 | - | $14.64 M(+0.0%) |
| Mar 2020 | - | $14.64 M(+0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $14.63 M(-11.7%) | $14.63 M(+0.0%) |
| Sep 2019 | - | $14.63 M(+0.0%) |
| Jun 2019 | - | $14.62 M(-4.0%) |
| Mar 2019 | - | $15.22 M(-8.1%) |
| Dec 2018 | $16.57 M(-16.5%) | $16.57 M(-13.1%) |
| Sep 2018 | - | $19.07 M(-4.1%) |
| Jun 2018 | - | $19.89 M(+0.1%) |
| Mar 2018 | - | $19.87 M(+0.1%) |
| Dec 2017 | $19.86 M(-15.1%) | $19.86 M(>+9900.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(-100.0%) |
| Dec 2014 | $23.40 M(>+9900.0%) | $23.40 M(>+9900.0%) |
| Dec 2013 | $0.00 | $0.00(-100.0%) |
| Sep 2012 | - | $115.00 K(-97.8%) |
| Jun 2012 | - | $5.20 M(+1280.4%) |
| Dec 2011 | - | $377.00 K |
FAQ
- What is Regulus Therapeutics annual short term debt?
- What is the all time high annual short term debt for Regulus Therapeutics?
- What is Regulus Therapeutics annual short term debt year-on-year change?
- What is the all time high quarterly short term debt for Regulus Therapeutics?
What is Regulus Therapeutics annual short term debt?
The current annual short term debt of RGLS is $1.33 M
What is the all time high annual short term debt for Regulus Therapeutics?
Regulus Therapeutics all-time high annual short term debt is $23.40 M
What is Regulus Therapeutics annual short term debt year-on-year change?
Over the past year, RGLS annual short term debt has changed by -$3.18 M (-70.43%)
What is the all time high quarterly short term debt for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly short term debt is $23.40 M